Prioritization of predisposition genes for familial non-medullary thyroid cancer by whole-genome sequencing
European Journal of Endocrinology · 2025
DOI: 10.1093/ejendo/lvaf045 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2025. Verfasst von Aayushi Srivastava und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Genetic Predisposition to Disease, Whole Genome Sequencing, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Science Agency, National Institute for Cancer Research, NICR.
Abstract (Originalsprache)
Objective
Thyroid cancer (TC) is the most common endocrine malignancy, with 90%-95% of the cases representing non–medullary thyroid cancer (NMTC). Familial cases account only for a few of all cases and the underlying genetic causes are still poorly understood.
Methods
We whole-genome sequenced affected and unaffected members of an Italian NMTC family and applied our in-house developed Familial Cancer Variant Prioritization Pipeline (FCVPPv2) which prioritized 12 coding variants. We refined this selection using the VarSome American College of Medical Genetics and Genomics (ACMG) implementation, SNAP2 predictions and further in silico scores.
Results
We prioritized 4 possibly pathogenic variants in 4 genes including Ret proto-oncogene (RET), polypeptide N-acetylgalactosaminyltransferase 10 (GALNT10), ubinuclein-1 (UBN1), and prostaglandin I2 receptor (PTGIR). The role of RET point mutations in medullary thyroid carcinoma is well established. Similarly, somatic rearrangements of RET are known in papillary TC, a specific histotype of NMTC. In contrast to RET, no germline variants in PTGIR, GALNT10, or UBN1 have been linked to the development of TC to date. However, alterations in these genes have been shown to affect pathways related to cell proliferation, apoptosis, growth, and differentiation, as well as posttranslational modification and gene regulation. A thorough review of the available literature together with computational evidence supported the interpretation of the 4 shortlisted variants as possibly disease-causing in this family.
Conclusions
Our results implicate the first germline variant in RET in a family with NMTC as well as the first germline variants in PTGIR, GALNT10, and UBN1 in TC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
- Heidelberg University, Medical Faculty, Heidelberg 69120, Germany.
- Department of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, Heidelberg 69120, Germany.
- Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT), Heidelberg 69120, Germany.
- Clinical Cooperation Unit Molecular Hematology-Oncology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
- Unit of Medical Genetics, Department of Medical and Surgical Sciences, University of Bologna, Bologna 40126, Italy.
ORCID-Profile: Asta Försti, Kari Hemminki
Förderung
- Czech Science Agency
- National Institute for Cancer Research
- NICR
- European Union-Next Generation EU
- SALVAGE
- European Union—Next Generation EU
Zitieren
APA
Srivastava, A., Skopelitou, D., Miao, B., Giagiobbe, S., Paramasivam, N., Kumar, A., Diquigiovanni, C., Bonora, E., Bandapalli, O. R., Försti, A., & Hemminki, K. (2025). Prioritization of predisposition genes for familial non-medullary thyroid cancer by whole-genome sequencing. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvaf045
Vancouver
Srivastava A, Skopelitou D, Miao B, Giagiobbe S, Paramasivam N, Kumar A, et al. Prioritization of predisposition genes for familial non-medullary thyroid cancer by whole-genome sequencing. European Journal of Endocrinology. 2025. doi:10.1093/ejendo/lvaf045
BibTeX
@article{Srivastava2025,
author = {Srivastava, Aayushi and Skopelitou, Diamanto and Miao, Beiping and Giagiobbe, Sara and Paramasivam, Nagarajan and Kumar, Abhishek and Diquigiovanni, Chiara and Bonora, Elena and Bandapalli, Obul Reddy and Försti, Asta and Hemminki, Kari},
title = {Prioritization of predisposition genes for familial non-medullary thyroid cancer by whole-genome sequencing},
journal = {European Journal of Endocrinology},
year = {2025},
doi = {10.1093/ejendo/lvaf045}
}
EUVIMED